A carregar...
Vascular endothelial growth factor (VEGF)-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma
INTRODUCTION: Adult “translocation” renal cell carcinoma (RCC), bearing TFE3 gene fusions at Xp11.2, is a recently recognized unique entity for which prognosis and therapy remain poorly understood. We investigated the effect of vascular-endothelial growth factor (VEGF)-targeted therapy in this disti...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4667556/ https://ncbi.nlm.nih.gov/pubmed/20665500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25512 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|